Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress

Stock Information for Pharmagreen Biotech Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Pharmagreen Biotech Inc

Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project
PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its' Nutraceutical Formulations
PHBI - Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic(TM) Supplement Product
Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development
PHBI Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch
PHBI - Pharmagreen Provides Updates On Its Business Developments Beyond Just Cannabis

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.